Cutaneous peripheral nerve sheath tumors in 15 dogs.
- Author:
Seung Bo KO
1
;
Kyoung Ok SONG
;
Sang Chul KANG
;
Jae Hoon KIM
Author Information
1. College of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University, Jeju 690-756, Korea. kimjhoon@jejunu.ac.kr
- Publication Type:Original Article
- Keywords:
dog;
immunohistochemistry;
peripheral nerve sheath tumors;
Schwann cell;
spindle cell
- MeSH:
Abdomen;
Animals;
Diagnosis;
Dogs*;
Female;
Fibroblasts;
Forelimb;
Giant Cells;
Hindlimb;
Hospitals, Animal;
Humans;
Immunohistochemistry;
Male;
Mammary Glands, Human;
Neck;
Necrosis;
Nerve Sheath Neoplasms*;
Peripheral Nerves*;
Schwann Cells;
Vimentin
- From:Korean Journal of Veterinary Research
2014;54(1):7-12
- CountryRepublic of Korea
- Language:English
-
Abstract:
Peripheral nerve sheath tumors (PNSTs) are heterogeneous tumor groups of peripheral nerves that originate from either Schwann cells or modified Schwann cells, fibroblasts, or perineural cells. In this study, signalment and clinical data such as tumor location and size were evaluated for 15 cases of PNSTs collected from local animal hospitals. The mean age of dogs with malignant PNST was higher than that of dogs with benign PNST. Additionally, the male to female ratio in dogs with PNST was 1 : 4. In dogs with PNST, the primary sites of involvement were the hindlimb, forelimb, around the mammary glands, the neck, and the abdomen. Histiopathologic examination revealed that eight PNSTs were benign and seven were malignant. The tumor cells were composed of loosely to densely arranged interlacing bundles and wavy spindle cells arranged in short bundles, palisading, and whirling. High mitotic figures, local invasion, multifocal necrosis and atypical multinucleated giant cells were observed in malignant PNST cases. All PNSTs showed immunoreactivity for vimentin and S-100. However, only 93.3% and 73.3% were immunoreactive for NSE and GFAP, respectively. Overall, these results indicated that immunohistochemical markers such as vimentin, S-100 and NSE could help confirm the diagnosis of canine PNSTs.
